BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Mar 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-02

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-02	Common Stock	M	15500	$39.06	Acquired	84176	Direct
2015-03-02	Common Stock	S	15500	$107	Disposed	68676	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-02	Stock Option (right to buy Common Stock)	$39.06	M	15500	Disposed	2022-05-28	Common Stock (15500)	Direct

Footnotes

F1: All shares sold at same price.

F2: Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter.

F3: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.